Statistical inference for heterogeneous treatment effect with right-censored data from synthesizing randomized clinical trials and real-world data. [PDF]
BiometricsMao G, Yang S, Wang X.
europepmc +1 more source
Partial identification with categorical data and nonignorable missing outcomes
Canadian Journal of Statistics, EarlyView.Abstract Nonignorable missing outcomes are common in real‐world datasets and often require strong parametric assumptions to achieve identification. These assumptions can be implausible or untestable, and so we may wish to forgo them in favour of partially identified models that narrow the set of a priori possible values to an identification region.
Daniel Daly‐Grafstein, Paul Gustafson
wiley +1 more source
Modeling Spatial Data with Heteroscedasticity Using PLVCSAR Model: A Bayesian Quantile Regression Approach. [PDF]
Entropy (Basel)Chen R, Chen Z.
europepmc +1 more source
A Markov approach to credit rating migration conditional on economic states
Canadian Journal of Statistics, EarlyView.Abstract We develop a model for credit rating migration that accounts for the impact of economic state fluctuations on default probabilities. The joint process for the economic state and the rating is modelled as a time‐homogeneous Markov chain. While the rating process itself possesses the Markov property only under restrictive conditions, methods ...
Michael Kalkbrener, Natalie Packham
wiley +1 more source
Deep generative model for the inverse design of Van der Waals heterostructures. [PDF]
Sci RepGao S +9 more
europepmc +1 more source
The law of one price: conditional convergence evidence from disaggregated data
, 2008 Peter Egger +2 more
openalex +2 more sources
Bayesian clustering of multivariate extremes
Canadian Journal of Statistics, EarlyView.Abstract The asymptotic dependence structure between multivariate extreme values is fully characterized by their projections on the unit simplex. Under mild conditions, the only constraint on the resulting distributions is that their marginal means must be equal, which results in a nonparametric model that can be difficult to use in applications ...
Sonia Alouini, Anthony C. Davison
wiley +1 more source
A dual enhanced stochastic gradient descent method with dynamic momentum and step size adaptation for improved optimization performance. [PDF]
Sci RepMokhtar MA, Fathy M, Dahab YA, Sayed EA.
europepmc +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.Momelotinib, a Janus kinase (JAK) 1/JAK2/activin A receptor type 1 inhibitor, is approved for the treatment of myelofibrosis with anemia. These analyses characterized the population pharmacokinetics of momelotinib and its active metabolite M21 following administration of the commercial tablet formulation in patients with myelofibrosis from phase II/III
Benjamin Rich +5 more
wiley +1 more source